Muscle Marketing USA, Inc. – Trademark Portfolio
Entity Type: 03
Muscle Marketing USA, Inc. holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 6 filings in this category. The portfolio also extends into Class 25 (Clothing) across 4 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include MMUSA. The owner is based in Lynnwood, WA.
12512 Beverly Park Rd., Suite B1B
Lynnwood, WA 98087
Showing of trademarks Trademarks
Trademark Classifications
Muscle Marketing USA, Inc.'s trademark portfolio spans 4 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Beers; mineral and aerated waters and other non-alcoholic beverages; fruit beverages
Coffee, tea, cocoa and artificial coffee; rice; tapioca and sago; flour and preparations
Frequently Asked Questions
How many trademarks does Muscle Marketing USA, Inc. have?
Muscle Marketing USA, Inc. has 7 U.S. trademarks filed with the USPTO. Of these, 1 registered, 6 abandoned.
What trademark classes does Muscle Marketing USA, Inc. file in?
Muscle Marketing USA, Inc. files trademarks across 4 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 25 (Clothing), Class 32 (Light Beverages), Class 30 (Staple Foods). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.
What are Muscle Marketing USA, Inc.'s most well-known trademarks?
Muscle Marketing USA, Inc.'s registered trademark portfolio includes well-known marks such as MMUSA. These are among 1 currently registered trademark in the portfolio.
What is Muscle Marketing USA, Inc.'s trademark registration success rate?
Muscle Marketing USA, Inc. has a 14% trademark registration rate, with 1 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.